《新股消息》GUANZE MEDICAL(02427.HK)今起招股 一手入場費3,181.75元
山東醫學影像解決方案供應商GUANZE MEDICAL(02427.HK)公布招股詳情,擬全球發售約1.93億股,香港公開發售佔一成,國際發售佔九成。每股招股價介乎0.53至0.63元。每手5,000股計,一手入場費3,181.75元。該股今日(15日)起招股,下周二(20日)中午截止,預期本月29日掛牌。獨家保薦人為西證國際。
公司上市引入3名基石投資者,包括Carsonlin Investment、慕敏及楊新雲,認購2,700萬元公司股份。
如以招股價中位數0.58元計,公司上市料淨集資約8,240萬元,當中約46.4%將用於延伸至山東省東部,以擴闊客戶基礎及進一步鞏固於山東省的市場地位;約37.3%將用於藉由策略性收購、取得醫療器械註冊證及將軟硬件升級以加強醫學影像雲服務的供應;約2.7%將用於擴大產品組合以橫向擴充價值鏈;約2.5%將用於藉由參與交易會、貿易展覽及會議以推廣品牌及增加市場知名度;約2.5%將用於資訊科技系統升級;約8.6%將用作額外營運資金及其他一般企業用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.